Therapy Discontinuation after Myocardial Infarction.
Lukasz PietrzykowskiMichał KasprzakPiotr MichalskiAgata Kosobucka-OzdobaTomasz FabiszakAldona KubicaPublished in: Journal of clinical medicine (2020)
The vast majority of post-MI patients discontinue, either temporarily or permanently, one of the essential medications within one year following myocardial infarction. The most likely medication class to be discontinued are statins. Older age and prior cardiac revascularization are independent determinants of therapy discontinuation.
Keyphrases
- end stage renal disease
- left ventricular
- ejection fraction
- chronic kidney disease
- newly diagnosed
- heart failure
- healthcare
- physical activity
- percutaneous coronary intervention
- stem cells
- coronary artery bypass grafting
- middle aged
- coronary artery disease
- bone marrow
- patient reported outcomes
- acute coronary syndrome
- community dwelling
- cell therapy
- atrial fibrillation
- patient reported
- adverse drug